Navigation Links
Mannatech to Open Centralized-Management Office in Switzerland
Date:1/10/2008

New office to assist in maximizing growth initiatives outside of North

America

COPPELL, Texas, Jan. 10 /PRNewswire-FirstCall/ -- Mannatech, Incorporated (Nasdaq: MTEX), a leading developer and provider of dietary supplements and skin care solutions, announced today it will open a management office in Switzerland to assist in maximizing international growth initiatives.

(Logo: http://www.newscom.com/cgi-bin/prnh/20051213/MANNATECHLOGO)

Scheduled to open during the first quarter of 2008, Mannatech Swiss International will help Mannatech strengthen its competitive position in Europe, Asia and other non-North American markets. Once fully developed, this centralized management team will be capable of responding more quickly to operational needs of Mannatech's burgeoning global markets in Asia and Europe.

"Global expansion is integral to Mannatech's strategic growth," said Terry Persinger, Mannatech's president and CEO. "Ultimately, Mannatech Swiss International will manage the day-to-day business needs of our growing non-North American markets and coordinate and oversee further global expansion."

About Mannatech

Mannatech, Incorporated, is a global wellness solutions provider of innovative, high-quality, proprietary nutritional supplements, topical and skin care products, and weight management products sold through independent associates and members located in the United States and the international markets of Canada, Australia, the United Kingdom, Japan, New Zealand, the Republic of Korea, Taiwan, Denmark, and Germany.

Please Note: This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as "intend" or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech's objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, Mannatech's inability to attract and retain associates and members, increases in competition, litigation, regulatory changes, and its planned growth into new international markets. Although Mannatech believes that the expectations, statements, and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.

Contact Information:

Gary Spinell, Vice President

Investor Relations

972-471-6512

ir@mannatech.com

Corporate website: http://www.mannatech.com


'/>"/>
SOURCE Mannatech, Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Mannatech Hosts Australasian Convention
2. Mannatech Hosts Japan National Convention
3. Mannatech Launches Phase One of New Sales and Training Tools
4. Office Furniture That Helps Fight Fat!
5. Isolagen Inc. Promotes Declan Daly to Chief Executive Officer (CEO)
6. Thermage, Inc. Appoints John F. Glenn as Chief Financial Officer
7. Grubb & Ellis Healthcare REIT Acquires Park Place Office Park in Dayton, Ohio
8. AlphaRx Officers and Directors To Exercise Options, Warrants and Retain Shares
9. Law Offices of Howard G. Smith Announces 25 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Threshold Pharmaceuticals, Inc.
10. University Hospitals Chief Executive Officer Extends Contract
11. James E. Harris to Become Chief Financial Officer of Coca-Cola Bottling Co. Consolidated
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... MD Now Urgent Care ... MD Now’s 28th facility overall and marks the urgent care center's eighth location in ... North of The Falls shopping mall. The new clinic offers a wide array of ...
(Date:6/23/2017)... ... ... American Farmer, will feature Chr. Hansen, Inc (CHR Hansen) in an upcoming episode ... Farmer airs Tuesdays at 8:30aET on RFD-TV. Check your local listings for more info. ... 1874 after a groundbreaking discovery of how to industrialize enzymes. Rooted in science and ...
(Date:6/23/2017)... Chicago, IL (PRWEB) , ... June 23, 2017 ... ... insurance management assistance and financial planning services to communities in the greater Chicago ... Children’s Association to offer assistance to underprivileged youth in Chicago. , Founded in ...
(Date:6/23/2017)... ... June 23, 2017 , ... Moore Insurance, ... area with access to asset protection and financial planning services, is teaming up ... improving the lives of children with cancer and other chronic diseases. , The ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... is pleased to welcome Whipple & Company as its newest Partner Firm. Headquartered ... of balancing their clients’ risk while tailoring optimized benefit packages that strengthen the ...
Breaking Medicine News(10 mins):
(Date:6/2/2017)... , June 2, 2017  NxStage Medical, Inc. (Nasdaq:  NXTM), a ... today announced new findings demonstrating positive biochemical outcomes related ... System One™. The data will be presented at the ... Madrid, Spain . The ... Home Dialysis Network in Europe ...
(Date:5/29/2017)... Israel, May 29, 2017  Cellect Biotechnology Ltd. (NASDAQ: ... technology which enables the functional selection of stem cells, ... for the first quarter ended March 31 st , ... our accomplishments in the first quarter of 2017," said ... quarter, we announced the treatment of the first blood ...
(Date:5/22/2017)... VALLEY COTTAGE, N.Y. , May 22, 2017 ... natural antiviral treatment Gene-Eden-VIR/Novirin, announces the launch of ... in plain English, the results of a clinical ... after one year treatment with Gene-Eden-VIR/Novirin in individuals ... is important to note that there are no ...
Breaking Medicine Technology: